Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
4.0
3.8
Journals
Bioengineering
Special Issues
Biopharmaceutical Process Development
share announcement

Biopharmaceutical Process Development

A special issue of Bioengineering (ISSN 2306-5354).

Deadline for manuscript submissions: closed (30 September 2014) | Viewed by 124995

Special Issue Editor

Prof. Dr. Christoph Herwig

E-Mail Website
Guest Editor
Lisalis GmbH, Jenbachgasse 73-2, 1130 Vienna, Austria
Interests: biopharmaceutical process development
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Process development for the industrial production of biopharmaceutical drug substances is still time consuming. In addition, the process continues to have a high risk to fail at the manufacturing scale, due to high variability of biological origin and of the various input materials.

Not long ago, the regulatory bodies launched the Quality by Design (QbD) initiative, which proposes a systematic, science driven and risk based approach to process development. However, the current interpretation of QbD is mainly data driven, using statistical approaches, identifying correlations (“How” parameters and attributes are correlated), without emphasizing “Why”. Therefore, QbD is perceived to be laborious and does not reach the full potential of its intention.

The current special issue emphasizes scientific and risk based methods to accelerate bioprocess development while allowing a mechanistic approach for process understanding and safe scale up. As a consequence, it is reviving QbD also as a new business opportunity.

We look forward to receiving your contributions to these cutting edge issues.

Prof. Dr. Christoph Herwig
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Bioengineering is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • integrated bioprocess development
  • microbial and mammalian host organisms
  • biopharmaceutical drugs
  • upstream and downstream processing
  • scale up, scale down models
  • multivariate explorative analysis
  • mechanistic modeling
  • hybrid modeling
  • bioprocess control

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (5 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

552 KiB  
Article
Modeling of Filtration Processes—Microfiltration and Depth Filtration for Harvest of a Therapeutic Protein Expressed in Pichia pastoris at Constant Pressure
by Muthukumar Sampath, Anupam Shukla and Anurag S. Rathore
Bioengineering 2014, 1(4), 260-277; https://doi.org/10.3390/bioengineering1040260 - 8 Dec 2014
Cited by 30 | Viewed by 11486
Abstract
Filtration steps are ubiquitous in biotech processes due to the simplicity of operation, ease of scalability and the myriad of operations that they can be used for. Microfiltration, depth filtration, ultrafiltration and diafiltration are some of the most commonly used biotech unit operations. [...] Read more.
Filtration steps are ubiquitous in biotech processes due to the simplicity of operation, ease of scalability and the myriad of operations that they can be used for. Microfiltration, depth filtration, ultrafiltration and diafiltration are some of the most commonly used biotech unit operations. For clean feed streams, when fouling is minimal, scaling of these unit operations is performed linearly based on the filter area per unit volume of feed stream. However, for cases when considerable fouling occurs, such as the case of harvesting a therapeutic product expressed in Pichia pastoris, linear scaling may not be possible and current industrial practices involve use of 20–30% excess filter area over and above the calculated filter area to account for the uncertainty in scaling. In view of the fact that filters used for harvest are likely to have a very limited lifetime, this oversizing of the filters can add considerable cost of goods for the manufacturer. Modeling offers a way out of this conundrum. In this paper, we examine feasibility of using the various proposed models for filtration of a therapeutic product expressed in Pichia pastoris at constant pressure. It is observed that none of the individual models yield a satisfactory fit of the data, thus indicating that more than one fouling mechanism is at work. Filters with smaller pores were found to undergo fouling via complete pore blocking followed by cake filtration. On the other hand, filters with larger pores were found to undergo fouling via intermediate pore blocking followed by cake filtration. The proposed approach can be used for more accurate sizing of microfilters and depth filters. Full article
(This article belongs to the Special Issue Biopharmaceutical Process Development)
►▼ Show Figures

Graphical abstract

7164 KiB  
Article
Characterization and Application of a Disposable Rotating Bed Bioreactor for Mesenchymal Stem Cell Expansion
by Anne Neumann, Antonina Lavrentieva, Alexandra Heilkenbrinker, Maren Loenne and Cornelia Kasper
Bioengineering 2014, 1(4), 231-245; https://doi.org/10.3390/bioengineering1040231 - 27 Nov 2014
Cited by 16 | Viewed by 8316
Abstract
Recruitment of mesenchymal stromal cells (MSC) into the field of tissue engineering is a promising development since these cells can be expanded vivo to clinically relevant numbers and, after expansion, retain their ability to differentiate into various cell lineages. Safety requirements and the [...] Read more.
Recruitment of mesenchymal stromal cells (MSC) into the field of tissue engineering is a promising development since these cells can be expanded vivo to clinically relevant numbers and, after expansion, retain their ability to differentiate into various cell lineages. Safety requirements and the necessity to obtain high cell numbers without frequent subcultivation of cells raised the question of the possibility of expanding MSC in one-way (single-use) disposable bioreactors. In this study, umbilical cord-derived MSC (UC-MSC) were expanded in a disposable Z 2000 H bioreactor under dynamic conditions. Z was characterized regarding residence time and mixing in order to evaluate the optimal bioreactor settings, enabling optimal mass transfer in the absence of shear stress, allowing an reproducible expansion of MSC, while maintaining their stemness properties. Culture of the UC-MSC in disposable Z 2000 H bioreactor resulted in a reproducible 8-fold increase of cell numbers after 5 days. Cells were shown to maintain specific MSC surface marker expression as well as trilineage differentiation potential and lack stress-induced premature senescence. Full article
(This article belongs to the Special Issue Biopharmaceutical Process Development)
►▼ Show Figures

Graphical abstract

939 KiB  
Article
An Integrated Downstream Process Development Strategy along QbD Principles
by Andrea Meitz, Patrick Sagmeister, Timo Langemann and Christoph Herwig
Bioengineering 2014, 1(4), 213-230; https://doi.org/10.3390/bioengineering1040213 - 24 Oct 2014
Cited by 11 | Viewed by 11065
Abstract
The development, optimization, and analysis of downstream processes are challenged by a high number of potentially critical process parameters that need to be investigated using lab-scale experiments. These process parameters are spread across multiple unit operations and potentially show interactions across unit operations. [...] Read more.
The development, optimization, and analysis of downstream processes are challenged by a high number of potentially critical process parameters that need to be investigated using lab-scale experiments. These process parameters are spread across multiple unit operations and potentially show interactions across unit operations. In this contribution, we present a novel strategy for bioprocess development that considers the risk of parameter interactions across unit operations for efficient experimental design. A novel risk assessment tool (interaction matrix) is introduced to the Quality by Design (QbD) workflow. Using this tool, the risk of interaction across unit operations is rated. Subsequently, a design of experiments (DoE) across unit operations is conducted that has the power to reveal multivariate interdependencies. The power of the presented strategy is demonstrated for protein isolation steps of an inclusion body process, focusing on the quality attribute inclusion body purity. The concentration of Triton X-100 in the course of inclusion body (IB) purification was shown to interact with the g-number of the subsequent centrifugation step. The presented strategy targets a holistic view on the process and allows handling of a high number of experimental parameters across unit operations using minimal experimental effort. It is generically applicable for process development along QbD principles. Full article
(This article belongs to the Special Issue Biopharmaceutical Process Development)
►▼ Show Figures

Figure 1

1637 KiB  
Article
Biopharmaceutical Process Optimization with Simulation and Scheduling Tools
by Demetri Petrides, Doug Carmichael, Charles Siletti and Alexandros Koulouris
Bioengineering 2014, 1(4), 154-187; https://doi.org/10.3390/bioengineering1040154 - 29 Sep 2014
Cited by 51 | Viewed by 20971
Abstract
Design and assessment activities associated with a biopharmaceutical process are performed at different levels of detail, based on the stage of development that the product is in. Preliminary “back-of-the envelope” assessments are performed early in the development lifecycle, whereas detailed design and evaluation [...] Read more.
Design and assessment activities associated with a biopharmaceutical process are performed at different levels of detail, based on the stage of development that the product is in. Preliminary “back-of-the envelope” assessments are performed early in the development lifecycle, whereas detailed design and evaluation are performed prior to the construction of a new facility. Both the preliminary and detailed design of integrated biopharmaceutical processes can be greatly assisted by the use of process simulators, discrete event simulators or finite capacity scheduling tools. This report describes the use of such tools for bioprocess development, design, and manufacturing. The report is divided into three sections. Section One provides introductory information and explains the purpose of bioprocess simulation. Section Two focuses on the detailed modeling of a single batch bioprocess that represents the manufacturing of a therapeutic monoclonal antibody (MAb). This type of analysis is typically performed by engineers engaged in the development and optimization of such processes. Section Three focuses on production planning and scheduling models for multiproduct plants. Full article
(This article belongs to the Special Issue Biopharmaceutical Process Development)
►▼ Show Figures

Figure 1

Review

Jump to: Research

538 KiB  
Review
Trends in Upstream and Downstream Process Development for Antibody Manufacturing
by Petra Gronemeyer, Reinhard Ditz and Jochen Strube
Bioengineering 2014, 1(4), 188-212; https://doi.org/10.3390/bioengineering1040188 - 1 Oct 2014
Cited by 246 | Viewed by 71744
Abstract
A steady increase of product titers and the corresponding change in impurity composition represent a challenge for development and optimization of antibody production processes. Additionally, increasing demands on product quality result in higher complexity of processes and analytics, thereby increasing the costs for [...] Read more.
A steady increase of product titers and the corresponding change in impurity composition represent a challenge for development and optimization of antibody production processes. Additionally, increasing demands on product quality result in higher complexity of processes and analytics, thereby increasing the costs for product work-up. Concentration and composition of impurities are critical for efficient process development. These impurities can show significant variations, which primarily depend on culture conditions. They have a major impact on the work-up strategy and costs. The resulting “bottleneck” in downstream processing requires new optimization, technology and development approaches. These include the optimization and adaptation of existing unit operations respective to the new separation task, the assessment of alternative separation technologies and the search for new methods in process development. This review presents an overview of existing methods for process optimization and integration and indicates new approaches for future developments. Full article
(This article belongs to the Special Issue Biopharmaceutical Process Development)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-5
Back to TopTop